Myocardial Hemodynamic Effects of Levosimendan.
Latest Information Update: 27 May 2013
Price :
$35 *
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 08 Jun 2010 Actual number of patients added to 20 as reported by ClinicalTrials.gov.
- 08 Jun 2010 Actual end date added to 1 Dec 2008 as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.